Stable Supply System Stable Supply of Medicines

Stable Supply Network and Decentralized Distribution Bases

We strive to reduce the risk of supply disruptions due to natural disasters and supply products under any circumstances by stockpiling pharmaceuticals at 12 distribution bases throughout Japan.

Decentralized Distribution of Manufacturing Bases for Stable Supply

By establishing four manufacturing bases throughout Japan, we aim to reduce the risk of supply disruptions due to natural disasters and to distribute our products under any circumstances.

Manufacturing base in eastern Japan for dialysis supplies and infusions/injections

Manufacturing base in western Japan for dialysis supplies and infusions/injections

Manufacturing base in western Japan for infusions/injections

Manufacturing base for oral drugs

For more information about Fuso Pharmaceutical’s offices and manufacturing bases, please click here.

Continuing to Provide a Stable Supply of dialysis supplies

To expand the stable supply of our main product, “Kindaly” dialysate for hemodialysis, a new powder-type dialysate production line has been in operation since 2024 in the second formulation building at the Ibaraki Factory.

Basic pharmaceutical products and Stable supplies

Basic pharmaceutical products

Drugs necessary for insured medical care have been used in the medical field for a long time, have established efficacy and stability, and are subject to NHI drug price measures because of the need to ensure a stable supply to the market.

Stable supplies

Drugs designated by major medical societies under the Japan Medical Association are medically indispensable, universal, and stable for each specialty.

Many Fuso Pharmaceutical Industries’ products, including dialysis supplies, infusions, and injections, are designated as “basic pharmaceutical products” or “stable supplies”.

Stable Supply System